Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Exel Composites' financial calendar and Annual General Meeting in 2021

EXEL COMPOSITES PLC                STOCK EXCHANGE RELEASE                30 OCTOBER 2020 11:00 EETExel Composites Plc will publish the following financial reports in 2021:  · Financial Statements Release 2020: 18 February 2021 at approximately 9:00 EET · Business Review Q1 2021: 30 April 2021 at approximately 9:00 EET · Half Year Financial Report Q1-Q2 2021: 20 July 2021 at approximately 10:00 EET · Business Review Q1-Q3 2021: 4 November 2021 at approximately 9:00 Annual Financial Report, including the Report of the Board the Directors as well as the financial statements,

Integrum’s OPRA™ Implant System now available at Froedtert & the Medical College of Wisconsin

Orthopaedic services at Froedtert & Medical College Wisconsin now include the OPRA™ Implant System for above-knee amputations.The Froedtert & the Medical College of Wisconsin health network is now using the OPRA™ Implant System, Integrum’s bone-anchored solution for the rehabilitation of amputees. The Froedtert & the Medical College of Wisconsin regional health network is a partnership between Froedtert Health and the Medical College of Wisconsin. The health network includes five hospitals, more than 1,700 physicians, and nearly 40 health centers and clinics, drawing patients from

I.A. Hedin Bil AB interim report Q3 2020

Hedin Bil delivers a strong quarter with focus on cost savings and liquidity.Gothenburg, 30th of October 2020 Operating profit during the second quarter was 240 MSEK, which was an improvement of 131 percent compared to last year’s third quarter. Net sales in comparable units increased by 21 percent compared to the same period last year. The operations in Sweden and Norway improved both operating profit and operating margin. The Belgian operations returned to show a profit after second quarter’s loss. New car sales increased by 2 percent in comparable units and the gross margin

Herantis Pharma Oyj : Managers' Transactions – Mats Heiman

Herantis Pharma Plc Company release 30 Oct 2020 at 9:00 am EET Herantis Pharma Oyj – Managers’ Transactions____________________________________________ Person subject to the notification requirement Name: Heiman, Mats Position: Closely associated person (1): Person Discharging Managerial Responsibilities In Issuer Name: Atteryd Heiman, Ingrid Position: Member of the Board Issuer: Herantis Pharma Oyj LEI: 743700W4CQVYAT3WKK38 Notification type: INITIAL NOTIFICATION Reference number: 743700W4CQVYAT3WKK38_20201029220801_12 _________________________________

Cyxone announces positive results from regulatory toxicology studies of Rabeximod

Cyxone (publ.), a Swedish biotech company developing disease modifying therapies for disorders of the immune system, today announced that the six-month regulatory toxicology studies of its drug candidate Rabeximod has been successfully concluded. A read-out of the study results shows a favorable safety profile for Rabeximod, thus enabling longer clinical studies in patients up to six months. Cyxone will now take the next step toward the initiation of a Phase 2 study in rheumatoid arthritis patients.The concluded six-month toxicology studies in two species are obligatory evaluations demanded

Press release 30.10.2020 New VTT-based startup company eniferBio producing protein from biorefinery by-products received more than one million euros in funding

The growing demand for food and sustainable food production are global challenges. A significant part of the problem is the lack of sustainably produced protein feed. eniferBio has developed a new and sustainable production process for a high-quality fish feed ingredient and recently received funding for its solution from two funds, Nordic FoodTech VC and Voima Ventures.Fish is healthier and more ecological source of protein than meat and its consumption is constantly increasing. The decline in fish stocks has led to the increased fish farming which, in turn, is limited to the availability

Wallenstam introduces digital mailboxes in all new production

Wallenstam is introducing digital mailboxes as standard in all new housing production. The mailboxes will be integrated with the properties’ digital entry system which will give the residents easy and secure access to their homes and their mail. Wallenstam’s existing residential properties, home for 10,000 families, will be included in stage two.“We currently have about 3,000 rental apartments in production. Quality, security and design have been important aspects in our agreement with Renz, which is our partner in this initiative,” says Patrik Persson, Technical Director at Wallenstam.

Change in number of shares and votes in Lagercrantz Group AB

The total number of shares and votes in Lagercrantz Group AB, reg. no. 556282-45556 (“Lagercrantz”) has changed in October 2020 consequent upon the Annual General Meeting in Lagercrantz held on 25 August 2020 resolving on a share split (3:1). Class A sharesBefore split                         Increased by                       New no.                              Total no. of votes3,263,802                           6,527,604                            9,791,406                            97,914,060 Class B shares66,256,125                         132,512,250

Altia: Publication of Q3 2020 Business Review on 6 November 2020 and invitation to a results presentation

Altia Plc  Press release  30 October 2020 at 10:00 am EET Altia: Publication of Q3 2020 Business Review on 6 November 2020 and invitation to a results presentation Altia will publish its Business Review for January–September 2020 on Friday 6 November at around 8:30 am EET. CEO Pekka Tennilä and interim CFO Juhana Jokinen will present the report on the same day at 11:00 am EET. The presentation will be held as a Microsoft Teams Meeting. We recommend that participants join the event using the online meeting option. Option A: Online meeting Access meeting online here: Altia's Q3

NENT Group and Elisa to launch combined streaming service Elisa Viihde Viaplay in December

· Elisa Viihde Viaplay available in Finland from 3 December · Service combines Viaplay’s ‘Films & Series’ package with Elisa Viihde Aitio · Elisa Viihde Viaplay priced at EUR 12.99 per month Nordic Entertainment Group (NENT Group), the Nordic region’s leading streaming company, and Elisa, Finland’s market-leading telecoms operator, will launch their combined streaming service Elisa Viihde Viaplay in Finland on 3 December. As previously announced , Elisa Viihde Viaplay will bring together Viaplay’s

Hans Djurberg SCA’s new Sustainability Director

Hans Djurberg has been appointed SCA’s new Sustainability Director. He will be responsible for the corporate sustainability agenda in parallel to his assignment as Sustainability Manager in business area Forest. Hans will take on his new position as of November 1 2020.  For further information, please contact: Björn Lyngfelt, Vice President Group Communication, +46 60 19 34 98 The core of SCA’s business is the forest, Europe’s largest private forest holding. Around this unique resource, we have built a well-developed value chain based on renewable raw material from our own and

New number of shares in Odd Molly

Odd Molly International AB (publ) Stockholm 30 October, 2020 Odd Molly International AB (publ) (“Odd Molly” or “the Company”) today announces that the number of shares and votes has increased by 17,326,778.As of today, the last trading day of the month, there are a total of 55,095,760 shares and votes in the Company. The share capital amounts to SEK 5,509,576. The new shares have been issued as consideration for acquired shares in real estate owning companies as well as due to directed cash issues. As a result, the number of shares and votes has increased by 17,326,778 from 37,768,

Change in the Number of Shares and Votes in Immunovia AB (publ)

Immunovia AB announced today that the number of shares and votes in Immunovia has changed due to a new share issue through the exercise of warrants in the company. The warrants that have been exercised form part of Immunovia's incentive program for senior executives and key personnel as decided at the 2017 Annual General Meeting. Through the registered shares after the new share issue, the number of outstanding shares and votes increases by 28,500 from 22,603,081 to 22,631,581. The share capital increases by SEK 1,425.00 from SEK 1,130,154.05 to SEK 1,131,579.05. For more information,

Inhalation Sciences receives new order worth 1.4 MSEK from VITO, the Flemish Institute for Technological Research

(Stockholm, 30 October 2020) One of Europe’s most innovative research organisations, driving new technology worldwide in sustainable health, chemistry, energy and land use, is purchasing PreciseInhale[®], ISAB’s high-precision aerosol R&D system, together with its Particle Size Determination kit and Inhaler Aerosol Generator option for both DPI and /pMDI inhalers. The combined value of the order is 1.4 MSEK.ISAB’s new customer develops new technology solutions in sustainability across a wide range of research areas. A major one is health – where the company partner with governments and

Kielo acquires in Helsinki Metropolitan Area (HMA)

The real estate company Kielo, managed by Brunswick Real Estate, has acquired an office property (Martintalo) in the Finnish city of Vantaa 20 kilometers outside Helsinki. The property built in 1992 comprises 14,000 square meters of office space and is located with good transportation and connections in Vantaa and greater Helsinki area.   Hanna Rauhala, Fund Manager at Brunswick Real Estate, says: “The Martintalo property with its great location and diversified tenant mix makes a perfect fit in the Kielo strategy and we believe we can further enhance the property with our

Correction: Fiskars Group interim report January-September 2020

Fiskars CorporationStock Exchange ReleaseOctober 30, 2020 at 9:30 a.m. (EET) Correction: Fiskars Group interim report January-September 2020This is a correction to Fiskars Corporation's Stock Exchange Release issued on October 30, 2020 at 8:30 EET regarding Fiskars' interim report January-September 2020. In the English version of the release, the figures for January-September 2020 in brief were incorrect. The figures in the attachment were correct.   Strong progress during the third quarter driven by exceptionally good demand in several categories as well as savings actions

Change in number of shares and votes in Endomines

Endomines AB, Stock Exchange Release 30 October 2020 at 08:30 CET The total number of shares and votes in Endomines AB (publ) ("Endomines") amounts to 131,305,175 as at 30 October 2020. The number of shares and votes in Endomines has increased by 15,392,535 during the month of October following the directed share issue to Transatlantic Mining informed on 8 of October, 2020. Following the above-mentioned measures, the shares in Endomines amount to 131,305,175 and the share capital amounts to SEK 394,385,153.61.Contact personMarcus Ahlström, Deputy CEO and CFO, +358 50 544 6814,

YIT Corporation’s financial reporting and Annual General Meeting in 2021

YIT Corporation   Stock Exchange Release   30 October 2020 at 9.30 a.m.YIT Corporation’s financial reporting and Annual General Meeting in 2021 YIT will publish the Financial Statements bulletin for 2020 on Wednesday, 3 February 2021. Financial Statements 2020 will be published during week 8/2021 at the latest. In addition, YIT will publish two interim reports and a half-year report in 2021: · Interim report for January-March on Friday, 30 April 2021 · Half-year report for January-June on Friday, 30 July 2021 · Interim report for January-September on Friday, 29 October 2021

SciBase releases next generation platform, Nevisense Go.

STOCKHOLM, SWEDEN, — October 30, 2020 – SciBase Holding AB ("SciBase") [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today the release of the first device based on their new platform, Nevisense Go.Nevisense Go is a handheld and fully portable device the size of a large Pen. It combines the company’s core Electrical Impedance Spectroscopy (EIS) measurement technology with a new AI-based analysis platform embedded in the device. The result is a flexible platform that will be significantly easier to both collect data and develop

Buy-backs of shares of series B in Saab during week 43-44 2020

During the period 23 October – 29 October 2020, Saab AB (publ) (LEI code 549300ZHO4JCQQI13M69) has repurchased in total 630.000 own shares of series B (ISIN: SE0000112385) as part of the share buy-back programme initiated by the Board of Directors in order to secure delivery of shares to participants in Saab’s long-term Share Matching Plan, Performance Share Plan and Special Projects Incentive.The share buy-back programme, which Saab announced on 16 September 2020, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 (“MAR”) and the Commission Delegated

NextCell publishes its Year-End Report

NextCell Pharma AB (publ) (NXTCL) publishes its Year-End Report for the period September 1, 2019 - August 31, 2020 The report is available on the company’s website: https://www.nextcellpharma.com/en/investors#financial-reportNextCells share is traded on Nasdaq First North Growth Market under the ticker "NXTCL". The amount in brackets refers to the corresponding period in the previous year.   Twelve months (2019-09-01 until 2020-08-31)● Operating income amounted to SEK 4 166 123 (1 964 132).● Operating result amounted to SEK -17 680 697 (-17 997 787).● Earnings per share* amounted

Atacand to be divested to Cheplapharm in more than 70 countries

30 October 2020 07:00 GMT Atacand to be divested to Cheplapharm in more than 70 countries Agreement supports strategy of focusing on newer medicines in main therapy areas AstraZeneca has agreed to sell the commercial rights to Atacand(candesartan cilexetil) and Atacand Plus (a fixed-dose combination of candesartan cilexetil and hydrochlorothiazide) in around 70 countries globally to Cheplapharm Arzneimittel GmbH (Cheplapharm). Atacand is a prescription medicine approved for the treatment of heart failure (HF) and hypertension. Atacand Plus is approved for the treatment of

There are no items matching the current filter
There are no more items matching the current filter
Back to top